Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Inhibitors of SARS-CoV-2 main protease: Biological efficacy and toxicity aspects.
Toxicol In Vitro. 2023 Oct;92:105640. doi: 10.1016/j.tiv.2023.105640. Epub 2023 Jul 5.
Toxicol In Vitro. 2023.
PMID: 37419426
To combat this virus, researchers have focused on developing antiviral strategies that target specific viral components, such as the main protease (M(pro)), which plays a crucial role in SARS-CoV-2 replication. While many compounds have been identified as potent inhibitors …
To combat this virus, researchers have focused on developing antiviral strategies that target specific viral components, such as the main pr …
The MatTek story - how the three Rs principles led to 3-D tissue success!
Sheasgreen J, Klausner M, Kandárová H, Ingalls D.
Sheasgreen J, et al.
Altern Lab Anim. 2009 Dec;37(6):611-22. doi: 10.1177/026119290903700606.
Altern Lab Anim. 2009.
PMID: 20104997
MatTek Corporation has been working diligently for over 15 years to replace traditional animal-based toxicity and efficacy tests with alternative test methods based on human-cell derived, three-dimensional (3-D) tissue models. First discussed in detail by W.M.S. Russell an …
MatTek Corporation has been working diligently for over 15 years to replace traditional animal-based toxicity and efficacy tests with altern …
Item in Clipboard
Cite
Cite